Narrow search
Showing 1 - 10 of 92
Cover Image
Pharmaceutical patents : incentives for R&D or marketing?
Brekke, Kurt R. (contributor); Straume, Odd Rune (contributor) - 2008
We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R … industry. Within a fairly general model framework, we derive exact conditions for advertising and R&D being substitute … strategies for the incumbent firm and show that it may overinvest in advertising to reduce the incentive for an entrant to invest …
Persistent link: https://www.econbiz.de/10003771873
Cover Image
Pharmaceutical patents: incentives for research and development or marketing?
Brekke, Kurt R.; Straume, Odd Rune - In: Southern economic journal 76 (2009) 2, pp. 351-374
Persistent link: https://www.econbiz.de/10003903146
Cover Image
Pharmaceutical patents : incentives for R&D or marketing?
Brekke, Kurt R. (contributor); Straume, Odd Rune (contributor) - 2005
Persistent link: https://www.econbiz.de/10003209183
Cover Image
Direct-to-consumer advertising in pharmaceutical markets
Brekke, Kurt R. (contributor); Kuhn, Michael (contributor) - 2003 - [Elektronische Ressource]
Persistent link: https://www.econbiz.de/10001753090
Cover Image
Direct-to-consumer advertising in pharmaceutical markets
Brekke, Kurt R.; Kuhn, Michael - 2003
Persistent link: https://www.econbiz.de/10001774715
Cover Image
Direct to consumer advertising in pharmaceutical markets
Brekke, Kurt R. (contributor); Kuhn, Michael (contributor) - 2005
We study effects of direct-to-consumer advertising (DTCA) in the prescription drug market. There are two pharmaceutical …
Persistent link: https://www.econbiz.de/10003110551
Cover Image
Direct to consumer advertising in pharmaceutical markets
Brekke, Kurt R.; Kuhn, Michael - 2005
We study effects of direct-to-consumer advertising (DTCA) in the prescription drug market. There are two pharmaceutical …
Persistent link: https://www.econbiz.de/10003041694
Cover Image
Direct to consumer advertising in pharmaceutical markets
Brekke, Kurt R.; Kuhn, Michael - In: Journal of health economics 25 (2006) 1, pp. 102-130
Persistent link: https://www.econbiz.de/10003251296
Cover Image
Does reference pricing drive out generic competition in pharmaceutical markets? : evidence from a policy reform
Brekke, Kurt R.; Canta, Chiara; Straume, Odd Rune - 2022
Policy makers use reference pricing to curb pharmaceutical expenditures by reducing coverage of expensive branded drugs. In a theoretical analysis we show that the net effect of reference pricing is generally ambiguous when accounting for entry by generic producers. Reference pricing shifts...
Persistent link: https://www.econbiz.de/10013285854
Cover Image
Reference pricing, competition, and pharmaceutical expenditures : theory and evidence from a natural experiment
Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2010
-savings, and that patients' copayments decrease despite the extra surcharges under RP. -- pharmaceuticals ; regulation ; generic …
Persistent link: https://www.econbiz.de/10008749029